ENTA Earnings Enanta Pharmaceuticals Inc
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q2 2026 | 2026-03-31 | -0.87 | 2026-05-13 | 10-Q |
| Q1 2026 | 2025-12-31 | -0.42 | 2026-02-11 | 10-Q |
| FY 2025 | 2025-09-30 | -3.84 | 2025-11-19 | 10-K |
| Q3 2025 | 2025-06-30 | -2.96 | 2025-08-13 | 10-Q |
| Q2 2026 | 2025-03-31 | -2.11 | 2026-05-13 | 10-Q |
| Q1 2026 | 2024-12-31 | -1.05 | 2026-02-11 | 10-Q |
| FY 2025 | 2024-09-30 | -5.48 | 2025-11-19 | 10-K |
| Q3 2025 | 2024-06-30 | -4.12 | 2025-08-13 | 10-Q |
| Q2 2025 | 2024-03-31 | -3.06 | 2025-05-14 | 10-Q |
| Q1 2024 | 2023-12-31 | -1.58 | 2025-02-12 | 10-Q |
| FY 2025 | 2023-09-30 | -6.38 | 2025-11-19 | 10-K |
| Q3 2024 | 2023-06-30 | -5.05 | 2024-08-07 | 10-Q |
| Q2 2024 | 2023-03-31 | -3.19 | 2024-05-08 | 10-Q |
| Q1 2024 | 2022-12-31 | -1.39 | 2024-02-08 | 10-Q |
| FY 2024 | 2022-09-30 | -5.91 | 2024-11-27 | 10-K |
| Q3 2023 | 2022-06-30 | -4.64 | 2023-08-08 | 10-Q |
| Q2 2023 | 2022-03-31 | -3.11 | 2023-05-09 | 10-Q |
| Q1 2023 | 2021-12-31 | -1.48 | 2023-02-08 | 10-Q |
| FY 2023 | 2021-09-30 | -3.92 | 2023-11-22 | 10-K |
| Q3 2022 | 2021-06-30 | -2.70 | 2022-08-08 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.